MRT-2359

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameMRT-2359
Drug Alias NameMolecular GlueMRT-2359
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionProteolysisEukaryotic peptide chain release factor GTP-binding subunit ERF3A degraders
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3A
Therapy Area/IndicationsHR-positive breast cancerProstatic NeoplasmsSmall Cell Lung Carcinoma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMonte Rosa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMonte Rosa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHR-positive breast cancerProstatic NeoplasmsSmall Cell Lung Carcinoma +[6] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A